Bamlanivimab [CAS 2423943-37-5]
Partner: MedChemexpress LLC
| CAS No: | 2423943-37-5 |
| Applications: | COVID-19-anti-virus |
| MW: | N/A |
| Formula: | N/A |
| SMILES: | [Bamlanivimab] |
| Purity: | 99.97 |
| Description: | Bamlanivimab (Anti-Human SARS-CoV-2) is the first COVID-19 monoclonal antibody (mAb) to be granted Emergency Use Authorization (EUA) in November 2020 by the U.S. Food and agent Administration (FDA). However, Bamlanivimab is withdrawn in April 2021 following the rise of SARS-CoV-2 virus variants resistant to Bamlanivimab[1]. |
| Shipping Conditions: | Ship on dry ice |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
